JIANGXI QIANBI TECHNOLOGY CO., LTD. – Trademark Portfolio

Entity Type: 99

JIANGXI QIANBI TECHNOLOGY CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include KOJYOCYO. The owner is based in NANCHANG CITY, JIANGXI PROVINCE.

ROOM 455, XINFENG BRANCH OFFICE BUILDING, TIEHE

TOWNSHIP, XINJIAN DISTRICT

NANCHANG CITY, JIANGXI PROVINCE 330000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

KOJYOCYO
KOJYOCYO
Registered 2024

Trademark Classifications

JIANGXI QIANBI TECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does JIANGXI QIANBI TECHNOLOGY CO., LTD. have?

JIANGXI QIANBI TECHNOLOGY CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does JIANGXI QIANBI TECHNOLOGY CO., LTD. file in?

JIANGXI QIANBI TECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are JIANGXI QIANBI TECHNOLOGY CO., LTD.'s most well-known trademarks?

JIANGXI QIANBI TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as KOJYOCYO. These are among 1 currently registered trademark in the portfolio.

What is JIANGXI QIANBI TECHNOLOGY CO., LTD.'s trademark registration success rate?

JIANGXI QIANBI TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.